Bookimed does not add extra charges for Online Consultation with Oncologist prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your Online Consultation with Oncologist upon your arrival.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Online Consultation with Oncologist and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Online Consultation with Oncologist journey.
| The USA | Turkey | Mexico | |
| Online Consultation with Oncologist | from $750 | from $250 | from $288 |
Clinic HM Nou Delfos is a comprehensive medical-surgical center in Barcelona, which is a part of the largest network in Spain – HM Hospitals. HM Delfos specializes in surgery, oncology, orthopedics, cardiology, gynecology, urology, neurology including diagnosis and treatment of epilepsy. The clinic is equipped with the very latest devices for diagnostics and treatment: EOS for high-precision images of the musculoskeletal system, CT and MRI, two units for radiotherapy of tumors without surgery.
The clinic has also the agreement with Institut Guttmann, neurorehabilitation hospital with JCI, AQU Catalunya, and ISO quality certificates for rehabilitation.
Dr. Lana Bijelic is an oncological surgeon and specialist in peritoneal carcinomatosis who joined the Teknon Oncology Institute’s Carcinomatosis Surgical Group in 2019. She is certified by the American Board of Surgery and is a member of various scientific communities, including the American College of Surgeons and the Society of Surgical Oncology. She has held various research and clinical positions, and has been awarded numerous academic achievements.
This doctor has experience in endocrine treatment, collaborating on studies aimed at overcoming resistance to hormone therapy. They have also been involved in numerous phase 1, 2 and 3 studies in breast and melanoma, which have led to the approval of new drugs in new indications. Their main area of interest lies in immunotherapy for melanoma treatment and patient care. They have participated in trials that have led to the approval of cdk4/6 palbociclib and ribociclib inhibitors in the first line of metastatic breast cancer, and Pembrolizumab in the first line of metastatic melanoma, as well as the combination of Nivolumab and Ipilimumab. They are a member of the Breast Cancer Unit and Melanoma Unit at the Vall d'Hebron University Hospital and the Vall d'Hebron Institute of Oncology. This doctor is an experienced oncologist with expertise in breast cancer and melanoma treatments, including endocrine therapy, immunotherapy, and patient care. They have been involved in numerous clinical trials leading to the approval of new drugs in new indications.
Professor Felip is a medical doctor from the UAB who specializes in thoracic malignancy management and is responsible for thoracic cancer trials. She is a current member of various societies related to oncology and has authored many peer-reviewed articles and book chapters in the field. She is also an associate professor at the UAB and professor of medicine at the Universitat de Vic, and is involved in the training of medical students and residents.